Journals / Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi / 2026 / Cilt: 6 Sayı: Ek Sayı 2

Comorbidity of Cardiac Rhabdomyoma, Early-Onset Epilepsy, and Atypical Autism in the TAND Spectrum in Tuberous Sclerosis Complex: A Case Report

Tuberoskleroz Kompleksinde Kardiyak Rabdomyom, Erken Başlangıçlı Epilepsi ve TAND Spektrumunda Atipik Otizm Komorbiditesi: Bir Olgu Sunumu

Gül Yücel(İNÖNÜ ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-5753-9048
Bilge Özgör(İNÖNÜ ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-6697-7629
Pages
30–33
Publication Date
2026-03-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This case demonstrates the devastating impact of TAND and epilepsy related regression on development and the importance of multidisciplinary follow-up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome that results from mutations in the TSC1 or TSC2 genes, causing multisystemic hamartomatosis.
📊
Key Findings & Data:Case Presentation: A male patient who underwent surgery for cardiac rhabdomyoma causing left ventricular outflow tract stenosis in the neonatal period had his first seizure with status epilepticus at the age of 13-14 months.
💡
Conclusion & Impact:Conclusion: This case demonstrates the devastating impact of TAND and epilepsy related regression on development and the importance of multidisciplinary follow-up.
🔬Design:Konferans Bildirisi
📍Scope:Comprehensive Sample
⚙️Variables:Tuberoskleroz kompleksi · tuberoskleroz ilişkili nöropsikiyatrik bozukluklar · TAND

Abstract

Introduction: Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome that results from mutations in the TSC1 or TSC2 genes, causing multisystemic hamartomatosis. This case report describes a case with atypical autism and early-onset epilepsy in the spectrum of tuberous sclerosis-associated neuropsychiatric disorders (TAND). Case Presentation: A male patient who underwent surgery for cardiac rhabdomyoma causing left ventricular outflow tract stenosis in the neonatal period had his first seizure with status epilepticus at the age of 13-14 months. At approximately four years of age, he was diagnosed with developmental regression and atypical autism, thought to be related to active epileptic abnormalities. Cranial magnetic resonance imaging revealed cortical tubers and subependymal nodules. Genetic analysis revealed a pathogenic variant (c.1309C>T, p.(Arg437Ter)) in the TSC1 gene. Conclusion: This case demonstrates the devastating impact of TAND and epilepsy related regression on development and the importance of multidisciplinary follow-up.

Özet

Giriş: Tuberoskleroz kompleksi (TSC), TSC1 veya TSC2 genlerindeki mutasyonlar sonucu ortaya çıkan, multisistemik hamartomatozise yol açan otozomal dominant bir nörokutanöz sendromdur. Bu olgu sunumu, tuberoskleroz ilişkili nöropsikiyatrik bozukluklar (TAND) spektrumundaki atipik otizm ve erken başlangıçlı epilepsi ile seyreden bir hastayı ele almaktadır. Olgu Sunumu: Yenidoğan döneminde sol ventrikül çıkış yolu darlığına neden olan kardiyak rabdomyom nedeniyle opere edilen erkek hasta, 13- 14 aylıkken status epileptikus tablosunda ilk nöbetini geçirmiştir. Yaklaşık dört yaşlarında ise, aktif epileptik anormalilerle ilişkili olduğu düşünülen gelişimsel regresyon ve atipik otizm tanısı almıştır. Kraniyal manyetik rezonans görüntülemesinde kortikal tuberler ve subependimal nodüller saptanmıştır. Genetik analizde ise TSC1 geninde patojenik bir varyant (c.1309C>T, p.(Arg437Ter)) belirlenmiştir. Sonuç: Bu olgu, TAND ve epilepsiye bağlı gerilemenin gelişim üzerindeki yıkıcı etkisini ve multidisipliner takibin önemini göstermektedir.

🔖

Cite This Article

Yücel, G., Özgör, B. (2026). Comorbidity of Cardiac Rhabdomyoma, Early-Onset Epilepsy, and Atypical Autism in the TAND Spectrum in Tuberous Sclerosis Complex: A Case Report. Yüksek İhtisas Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 6 Sayı: Ek Sayı 2, 30–33. https://ajindex.com/articles/1647692

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015 Jul;14(7):733-45. doi: 10.1016/S1474-4422(15)00069-1. PMID: 26067126.
  2. Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, Frost MD, Fuchs Z, Gosnell ES, Gupta N, Jansen AC, Jóźwiak S, Kingswood JC, Knilans TK, McCormack FX, Pounders A, Roberds SL, Rodriguez-Buritica DF, Roth J, Sampson JR, Sparagana S, Thiele EA, Weiner HL, Wheless JW, Towbin AJ, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021 Oct;123:50-66. doi: 10.1016/j.pediatrneurol.2021.07.011. Epub 2021 Jul 24. PMID: 34399110.
  3. de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, Hook D, King BH, Sahin M, Jansen A. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatr Neurol. 2015 Jan;52(1):25-35. doi: 10.1016/j.pediatrneurol.2014.10.004. Epub 2014 Oct 16. PMID: 25532776; PMCID: PMC4427347.
  4. de Vries PJ, Wilde L, de Vries MC, Moavero R, Pearson DA, Curatolo P. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):309-320. doi: 10.1002/ajmg.c.31637. Epub 2018 Aug 16. PMID: 30117265; PMCID: PMC6209538.
  5. Kingswood JC, d'Augères GB, Belousova E, Ferreira JC, Carter T, Castellana R, Cottin V, Curatolo P, Dahlin M, de Vries PJ, Feucht M, Fladrowski C, Gislimberti G, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Nabbout R, O'Callaghan F, Benedik MP, Qin J, Marques R, Sander V, Sauter M, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Jansen AC; TOSCA consortium and TOSCA investigators. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients. Orphanet J Rare Dis. 2017 Jan 5;12(1):2. doi: 10.1186/s13023-016-0553-5. PMID: 28057044; PMCID: PMC5217262.
  6. Spurling Jeste S, Wu JY, Senturk D, Varcin K, Ko J, McCarthy B, Shimizu C, Dies K, Vogel-Farley V, Sahin M, Nelson CA 3rd. Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex. Neurology. 2014 Jul 8;83(2):160-8. doi: 10.1212/WNL.0000000000000568. Epub 2014 Jun 11. PMID: 24920850; PMCID: PMC4117170.
  7. Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology. 2011 Mar 15;76(11):981-7. doi: 10.1212/WNL.0b013e3182104347. PMID: 21403110; PMCID: PMC3271577.
  8. Jeste SS, Sahin M, Bolton P, Ploubidis GB, Humphrey A. Characterization of autism in young children with tuberous sclerosis complex. J Child Neurol. 2008 May;23(5):520-5. doi: 10.1177/0883073807309788. Epub 2007 Dec 26. PMID: 18160549.
  9. Mitchell RA, Mitchell M, Williams K. The autism spectrum disorder phenotype in children with tuberous sclerosis complex: A systematic review and meta-analysis. Dev Med Child Neurol. 2022 Oct;64(10):1214-1229. doi: 10.1111/dmcn.15307. Epub 2022 Jun 20. PMID: 35724267.
  10. de Vries PJ, Leclezio L, Gardner-Lubbe S, Krueger D, Sahin M, Sparagana S, De Waele L, Jansen A. Multivariate data analysis identifies natural clusters of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND). Orphanet J Rare Dis. 2021 Oct 24;16(1):447. doi: 10.1186/s13023-021-02076-w. PMID: 34689816; PMCID: PMC8543869.
  11. Capal JK, Williams ME, Pearson DA, Kissinger R, Horn PS, Murray D, Currans K, Kent B, Bebin M, Northrup H, Wu JY, Sahin M, Krueger DA; TACERN Study Group. Profile of Autism Spectrum Disorder in Tuberous Sclerosis Complex: Results from a Longitudinal, Prospective, Multisite Study. Ann Neurol. 2021 Dec;90(6):874-886. doi: 10.1002/ana.26249. Epub 2021 Oct 29. PMID: 34668231; PMCID: PMC8639652.
  12. Rentz AM, Skalicky AM, Liu Z, Wheless JW, Dunn DW, Frost MD, Nakagawa J, Magestro M, Prestifilippo J. Tuberous sclerosis complex: a survey of health care resource use and health burden. Pediatr Neurol. 2015 Apr;52(4):435-41. doi: 10.1016/j.pediatrneurol.2014.11.013. Epub 2014 Nov 29. PMID: 25771998.
  13. Moavero R, Voci A, La Briola F, Matricardi S, Toldo I, Mancardi MM, Negrin S, Messana T, Mazzone L, Valeriani M, Curatolo P, Bruni O. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study. Sleep Med. 2022 Jan;89:65-70. doi: 10.1016/j.sleep.2021.11.010. Epub 2021 Dec 1. PMID: 34915263.
  14. Hwang SK, Lee JH, Yang JE, Lim CS, Lee JA, Lee YS, Lee K, Kaang BK. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation. Mol Brain. 2016 May 23;9(1):56. doi: 10.1186/s13041-016-0222-6. PMID: 27216612; PMCID: PMC4878062.